By comparing different breast cancer cell lines, we found that pretreatment with retinoic acid can antagonize chemotherapy-induced cell death in a cell- dependent manner, which correlates with the activation of NF-κB/cIAP2 signaling pathway(s). This evidence concerns the gene NFKB1 and breast carcinoma.